Thromboplastin

Thromboplastin is a plasma protein aiding blood coagulation through conversion of prothrombin to thrombin.

Although sometimes used as a synonym for tissue factor, this is a misconception. Historically, thromboplastin was a lab reagent, usually derived from placental sources, used to assay prothrombin times (PT time). Thromboplastin, by itself, could activate the extrinsic coagulation pathway. When manipulated in the laboratory, a derivative could be created called partial thromboplastin. Partial thromboplastin was used to measure the intrinsic pathway. This test is called the aPTT, or activated partial thromboplastin time. It was not until much later that the subcomponents of thromboplastin and partial thromboplastin were identified. Thromboplastin is the combination of both phospholipids and tissue factor, both needed in the activation of the extrinsic pathway. However, partial thromboplastin is just phospholipids, and not tissue factor.

Currently, recombinant tissue factor is available and used in some PT assays. Placental derivatives are still available and used in some laboratories. Phospholipid is available as an independent reagent or in combination with tissue factor as thromboplastin. Complete thromboplastin consists of tissue factor, phospholipids (since platelets were removed from blood sample being tested), and CaCl₂ to reintroduce calcium ions that were chelated by sodium citrate originally used to prevent coagulation of the sample blood during transportation and/or storage.

References

• Kottke-Marchant, Kandice; "An Alogorithmic Approach to Hemostasis Testing"; CAP Press; Northfield, Il; Copyright 2008. ISBN 978-0-930304-93-5.

See also

• Tissue factor